National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
539
90
108
390
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
4.8%
26 terminated/withdrawn out of 539 trials
93.8%
+7.2% vs industry average
11%
59 trials in Phase 3/4
33%
130 of 390 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (539)
The Acquisition of Blood and Skin Samples From Normal Volunteers to Support Research Activities on Dermatologic Diseases
Role: lead
Natural History of Inflammatory Muscle Diseases
Role: lead
Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis
Role: lead
Effects of Treatments on Atopic Dermatitis
Role: lead
Feasibility Study for Fibroblast Autologous Skin Grafts
Role: collaborator
Frequency and Complications of Major Orthopedic Procedures in Medicare Beneficiaries
Role: lead
Studies of the Natural History of Rheumatic Diseases
Role: lead
Assessment of Treatment Variability for Pelvic Ring Fragility Fractures
Role: collaborator
Improving Health for Patients With Chronic Low Back Pain in Rural Communities Through Telerehabilitation
Role: collaborator
A Pilot of Pediatric/Adult Study of Gene Expression Profiling and Clinical Characterization of Phototoxicity
Role: lead
Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases Including Juvenile Dermatomyositis
Role: lead
Natural History and Pathogenesis of Alopecia in Children and Adults
Role: lead
Natural History and Development of Spondyloarthritis
Role: lead
Muscle Recovery After Critical Illness
Role: collaborator
Poly-L-Lactic Acid for Vulvovaginal Tissue Regeneration
Role: collaborator
FDG PET/MRI Imaging of Patellofemoral Joint Osteoarthritis
Role: collaborator
Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires
Role: lead
Implementation of the ACP Guideline for Low Back Pain (IMPACt-LBP)
Role: collaborator
Hormones, Outcomes, and Pain Pathways in Exercise Study
Role: collaborator
Natural History, Pathogenesis and Outcome of Melorheostosis A Rare Osteosclerotic Disease
Role: lead